As of January 22, 2025, HeartBeam (BEAT) has a market cap of $57.064 million USD. According to our data, HeartBeam is ranked No.8079 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $57.06 M |
-6.96%
|
Dec 31, 2024 | $61.33 M |
-2.13%
|
Dec 29, 2023 | $62.66 M |
-51.84%
|
Dec 30, 2022 | $0.13 B |
58.44%
|
Dec 31, 2021 | $82.13 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
HeartBeam
BEAT
|
$57.06 M |
0.000 M
|
USA
|
iRhythm
(ZIO)
IRTC
|
$3.47 B |
-0.000 M
|
USA
|
Medtronic
MDT
|
$112.66 B |
-0.001 M
|
Ireland
|
Boston Scientific
BSX
|
$147.80 B |
0.001 M
|
USA
|
Abbott Laboratories
ABT
|
$204.28 B |
0.006 M
|
USA
|
Philips
PHG
|
$24.48 B |
-0.001 M
|
Netherlands
|
General Electric
GE
|
$203.86 B |
-0.006 M
|
USA
|
Masimo
MASI
|
$9.27 B |
-0.000 M
|
USA
|
Edwards Lifesciences
EW
|
$40.72 B |
0.002 M
|
USA
|
Baxter
BAX
|
$16.25 B |
-0.000 M
|
USA
|
Stryker Corporation
SYK
|
$148.83 B |
-0.003 M
|
USA
|
Market Cap | = | BEAT Stock Price | * | BEAT Shares Outstanding |
= | $2.14 | * | 26.67 M | |
= | $57.06 M |